Cambridge, Mass.-based InVivo Therapeutics has named Steven McAllister as its interim CFO as of Dec. 31.
Mr. McAllister will replace Gregory Perry, who announced his resignation to join another biotechnology company.
Previously, Mr. McAllister served as vice president of finance and administration for Biomet Spine and Bone Healing Technologies.
More Articles on Devices:
3-D Printing for Medical Devices to Grow 15.4% Over 6 Years to $965M
Intellirod Spine Receives $1.6M From Ohio Commercial Acceleration Loan Fund
Integra LifeSciences Announces Publication of NeuraGen Nerve Guide Study
Previously, Mr. McAllister served as vice president of finance and administration for Biomet Spine and Bone Healing Technologies.
More Articles on Devices:
3-D Printing for Medical Devices to Grow 15.4% Over 6 Years to $965M
Intellirod Spine Receives $1.6M From Ohio Commercial Acceleration Loan Fund
Integra LifeSciences Announces Publication of NeuraGen Nerve Guide Study